Balance Sheet Data

Celldex Therapeutics, Inc. (CLDX)

$35.24

+0.46 (+1.32%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 94.0264.38194.42408.25304.95114.58102.6892.0182.4673.89
Total Cash (%)
Account Receivables 3.161.011.800.170.350.440.390.350.320.28
Account Receivables (%)
Inventories ----------
Inventories (%)
Accounts Payable 1.071.171.051.233.340.960.860.770.690.62
Accounts Payable (%)
Capital Expenditure -0.81-0.73-1.55-1.25-1.83-0.65-0.58-0.52-0.47-0.42
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.